Gene · 8784
Papers4,557
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,021 to 1,040 of 4,557
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Reconstitution of the immune system and clinical correlates after stem cell transplantation for systemic sclerosis. | Front Immunol | 2022 | 36032076 | PubTator, text mining | PubMed |
| The dark side of Tregs during aging. | Front Immunol | 2022 | 36016952 | PubTator, text mining | PubMed |
| Migration and homeostasis of regulatory T cells in rheumatoid arthritis. | Front Immunol | 2022 | 36016949 | PubTator, text mining | PubMed |
| Application of mRNA Technology in Cancer Therapeutics. | Vaccines (Basel) | 2022 | 36016150 | PubTator, text mining | PubMed |
| When Natural Compounds Meet Nanotechnology: Nature-Inspired Nanomedicines for Cancer Immunotherapy. | Pharmaceutics | 2022 | 36015215 | PubTator, text mining | PubMed |
| The Features of Immune Checkpoint Gene Regulation by microRNA in Cancer. | Int J Mol Sci | 2022 | 36012588 | PubTator, text mining | PubMed |
| IL11 Stimulates IL33 Expression and Proinflammatory Fibroblast Activation across Tissues. | Int J Mol Sci | 2022 | 36012165 | PubTator, text mining | PubMed |
| TNF Receptor Associated Factor 2 (TRAF2) Signaling in Cancer. | Cancers (Basel) | 2022 | 36011046 | PubTator, text mining | PubMed |
| Next Steps for Immunotherapy in Glioblastoma. | Cancers (Basel) | 2022 | 36011015 | PubTator, text mining | PubMed |
| Novel Necroptosis-Related Gene Signature for Predicting Early Diagnosis and Prognosis and Immunotherapy of Gastric Cancer. | Cancers (Basel) | 2022 | 36010886 | PubTator, text mining | PubMed |
| Expression of IL-37 Induces a Regulatory T-Cell-like Phenotype and Function in Jurkat Cells. | Cells | 2022 | 36010641 | PubTator, text mining | PubMed |
| Detailed spatial immunophenotyping of primary melanomas reveals immune cell subpopulations associated with patient outcome. | Front Immunol | 2022 | 36003398 | PubTator, text mining | PubMed |
| Fcγ receptor-mediated cross-linking codefines the immunostimulatory activity of anti-human CD96 antibodies. | JCI Insight | 2022 | 35998045 | PubTator, text mining | PubMed |
| High expression of cuproptosis-related SLC31A1 gene in relation to unfavorable outcome and deregulated immune cell infiltration in breast cancer: an analysis based on public databases. | BMC Bioinformatics | 2022 | 35996075 | PubTator, text mining | PubMed |
| Amino acid metabolism genes associated with immunotherapy responses and clinical prognosis of colorectal cancer. | Front Mol Biosci | 2022 | 35992263 | PubTator, text mining | PubMed |
| A genomic instability-related lncRNA model for predicting prognosis and immune checkpoint inhibitor efficacy in breast cancer. | Front Immunol | 2022 | 35990656 | PubTator, text mining | PubMed |
| Construction of a breast cancer prognosis model based on alternative splicing and immune infiltration. | Discov Oncol | 2022 | 35988113 | PubTator, text mining | PubMed |
| Single-Nucleus RNA Sequencing and Spatial Transcriptomics Reveal the Immunological Microenvironment of Cervical Squamous Cell Carcinoma. | Adv Sci (Weinh) | 2022 | 35986392 | PubTator, text mining | PubMed |
| Immune cellular components and signaling pathways in the tumor microenvironment. | Semin Cancer Biol | 2022 | 35985559 | PubTator, text mining | PubMed |
| Transcriptional Heterogeneity of Cellular Senescence in Cancer. | Mol Cells | 2022 | 35983702 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8784/papers?page=52